2015 to 2021 Saw Increase in Gabapentinoid Use
Authors say increase driven by off-label uses for chronic pain with lack of evidence supporting use
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Authors say increase driven by off-label uses for chronic pain with lack of evidence supporting use
Only registered members have full access to PracticeUpdate content.